CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-02 | Lowrance David L Chief Financial Officer | Exercise or conversion | +31,894 | $1.51 | $48K | 33,994 |
| 2018-01-02 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −3,239 | $15.06 | $49K | 30,755 |
| 2018-01-02 | Lowrance David L Chief Financial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −31,894 | 95,684 | ||
| 2017-12-17 | Elam Nevan C Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2017-12-17 | McCracken Joseph S Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2017-12-17 | PIKOVER YURI Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2017-12-17 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2017-10-27 | PIKOVER YURI Director | Purchase | +50,000 | $7.85 | $393K | 150,000 |
| 2017-06-07 | Neville Robert N Chief Executive Officer | Purchase | +52,250 | $4.75 | $248K | 430,385 |
| 2017-06-07 | RAMSAY DAVID A Director | Purchase | +21,000 | $4.75 | $100K | 22,428 |
| 2017-06-07 | PIKOVER YURI Director | Purchase | +100,000 | $4.75 | $475K | 100,000 |
| 2017-06-07 | Jouhikainen Jaakko Taneli | Purchase | +10,500 | $4.75 | $50K | 235,326 |
| 2017-06-07 | Lowrance David L Chief Financial Officer | Purchase | +2,100 | $4.75 | $10K | 2,100 |
| 2017-06-07 | McCracken Joseph S Director | Purchase | +52,250 | $4.75 | $248K | 59,866 |
| 2017-05-25 | RAMSAY DAVID A Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2017-05-25 | Pauls Matthew Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2017-04-27 | Pauls Matthew | Exercise or conversion | +650 | 650 | ||
| 2017-04-27 | Pauls Matthew | Exercise or conversion · Restricted Stock Units | −650 | 0 | ||
| 2017-04-27 | RAMSAY DAVID A Director | Exercise or conversion | +1,142 | 23,570 | ||
| 2017-04-27 | RAMSAY DAVID A Director | Exercise or conversion · Restricted Stock Units | −1,142 | 0 |
Page 19 of 20 · 390 trades